SE9802937D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9802937D0
SE9802937D0 SE9802937A SE9802937A SE9802937D0 SE 9802937 D0 SE9802937 D0 SE 9802937D0 SE 9802937 A SE9802937 A SE 9802937A SE 9802937 A SE9802937 A SE 9802937A SE 9802937 D0 SE9802937 D0 SE 9802937D0
Authority
SE
Sweden
Prior art keywords
novel compounds
triazole
therapy
processes
preparation
Prior art date
Application number
SE9802937A
Other languages
English (en)
Swedish (sv)
Inventor
Andrew Baxter
Colin Bennion
Nicholas Kindon
Michael Mortimore
Bryan Roberts
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9802937A priority Critical patent/SE9802937D0/xx
Publication of SE9802937D0 publication Critical patent/SE9802937D0/xx
Priority to JP2000571050A priority patent/JP2002525281A/ja
Priority to AU58923/99A priority patent/AU5892399A/en
Priority to AT99946526T priority patent/ATE240303T1/de
Priority to DE69907926T priority patent/DE69907926T2/de
Priority to EP99946526A priority patent/EP1109790B1/en
Priority to PCT/SE1999/001469 priority patent/WO2000012489A1/en
Priority to US10/006,245 priority patent/US20020086862A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE9802937A 1998-09-01 1998-09-01 Novel compounds SE9802937D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9802937A SE9802937D0 (sv) 1998-09-01 1998-09-01 Novel compounds
JP2000571050A JP2002525281A (ja) 1998-09-01 1999-08-27 １，２，４−トリアゾール−３−チオン化合物
AU58923/99A AU5892399A (en) 1998-09-01 1999-08-27 1, 2, 4-triazole-3-thione compounds
AT99946526T ATE240303T1 (de) 1998-09-01 1999-08-27 1,2,4-triazol-3-thion verbindungen
DE69907926T DE69907926T2 (de) 1998-09-01 1999-08-27 1,2,4-triazol-3-thion verbindungen
EP99946526A EP1109790B1 (en) 1998-09-01 1999-08-27 1, 2, 4-triazole-3-thione compounds
PCT/SE1999/001469 WO2000012489A1 (en) 1998-09-01 1999-08-27 1, 2, 4-triazole-3-thione compounds
US10/006,245 US20020086862A1 (en) 1998-09-01 2001-12-10 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802937A SE9802937D0 (sv) 1998-09-01 1998-09-01 Novel compounds

Publications (1)

Publication Number Publication Date
SE9802937D0 true SE9802937D0 (sv) 1998-09-01

Family

ID=20412435

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802937A SE9802937D0 (sv) 1998-09-01 1998-09-01 Novel compounds

Country Status (8)

Country Link
US (1) US20020086862A1 (xx)
EP (1) EP1109790B1 (xx)
JP (1) JP2002525281A (xx)
AT (1) ATE240303T1 (xx)
AU (1) AU5892399A (xx)
DE (1) DE69907926T2 (xx)
SE (1) SE9802937D0 (xx)
WO (1) WO2000012489A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2361003A (en) * 2000-04-07 2001-10-10 Astrazeneca Ab Novel compounds
NZ523659A (en) * 2000-07-18 2006-01-27 Smithkline Beecham Corp Use of IL-8 receptor antagonists in the treatment of virus infections
WO2004069809A1 (en) * 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
US7276050B2 (en) * 2004-03-02 2007-10-02 Alan Franklin Trans-scleral drug delivery method and apparatus
JP2007527911A (ja) * 2004-03-08 2007-10-04 ワイス イオンチャンネルモジュレーター
CA2573066A1 (en) * 2004-08-11 2006-02-16 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
WO2006103119A2 (en) * 2005-04-01 2006-10-05 Galderma Research & Development Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
FR2883875A1 (fr) * 2005-04-01 2006-10-06 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
AU2008337565A1 (en) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxiranes, use thereof and agents containing the same
BRPI0821362A2 (pt) * 2007-12-19 2014-10-14 Basf Se Composto, uso do mesmo, composição, semente, método para controlar fungos fitopatogênicos, medicamento, e, processos para preparar um antimicótico e para preparar compostos
BRPI0821746A2 (pt) * 2007-12-19 2015-06-16 Basf Se Composto, uso do mesmo, composição, semente, método para controlar fungos fitopatogênicos, medicamento, e, processos para preparar um antimicótico e para preparar compostos
TWI487705B (zh) 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
SG11201504622PA (en) * 2012-12-20 2015-07-30 Inception 2 Inc Triazolone compounds and uses thereof
CN103012233B (zh) * 2012-12-26 2015-08-26 华润赛科药业有限责任公司 一种n-(氨基硫代甲基)-5-氧代-1-丙基-2-吡咯烷乙酰胺的制备方法
EA201690230A1 (ru) 2013-09-06 2016-07-29 Инсепшн 2, Инк. Соединения триазолона и их применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators

Also Published As

Publication number Publication date
DE69907926T2 (de) 2004-02-19
EP1109790A1 (en) 2001-06-27
EP1109790B1 (en) 2003-05-14
JP2002525281A (ja) 2002-08-13
AU5892399A (en) 2000-03-21
US20020086862A1 (en) 2002-07-04
ATE240303T1 (de) 2003-05-15
WO2000012489A1 (en) 2000-03-09
DE69907926D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
DE69905170D1 (en) Thiazolopyrimidinderivate
SE9704546D0 (sv) Novel compounds
TR200100054T2 (tr) Paroksetin metansülfonat
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
HK1048990A1 (en) Novel compounds.
SE9802937D0 (sv) Novel compounds
TR200000152T2 (tr) Yeni bileşikler.
YU13301A (sh) Muskarinski agonisti i antagonisti
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
PL340459A1 (en) Agonists of 5ht1f
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
NO20005548L (no) Mykobakterieinhibitorer
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
RS47804A (xx) 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
PE61999A1 (es) Compuestos de tetrahidropiridina